| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/30/2008 | CN100384417C Pyranoindazoles and their use for the treatment of glaucoma |
| 04/29/2008 | US7365201 Process for the preparation of the boron difluoride chelate of quinolone-3-carboxylic acid |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 04/29/2008 | US7365079 2-(2-naphthyl)-4'-[3-oxospiro[6-azaisobenzofuran-1(3H),1-cyclohexan]-4'-yl]-1H-imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 04/29/2008 | US7365078 Triaza-cyclopenta[cd]indene derivatives |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008021015A3 Methods of making esters of camptothecins |
| 04/24/2008 | US20080097094 cis-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release; Alzheimer's disease, Parkinson's disease, attention deficit disorder, depression, nicotinic withdrawal syndrome, Tourette's syndrome, schizophrenia and pain |
| 04/24/2008 | US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096862 Lactam compounds and pharmaceutical use thereof |
| 04/24/2008 | US20080096048 Thermally reversible; absorption ratio greater than 2.3 |
| 04/23/2008 | EP1913003A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES |
| 04/23/2008 | EP1913002A2 Method of acylating maytansinol with chiral amino acids |
| 04/23/2008 | EP1912998A1 Pyrazole derivatives having tyrosinkinase activity |
| 04/23/2008 | EP1912982A2 Novel heterocyclic nf- b inhibitors |
| 04/23/2008 | EP1912980A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1912642A2 Synthesis and crystalline forms of npy5 antagonist |
| 04/23/2008 | EP1534716B1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166744A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | CA2225807C Use of lamellarin-class alkaloids in methods of treatment |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046046A1 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
| 04/17/2008 | WO2008044701A1 Method for producing piperidin-4-one derivative |
| 04/17/2008 | WO2008044045A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008043791A2 Thiophene derivatives for treating hepatitis c |
| 04/17/2008 | US20080091022 Reacting methscopolammonium bromide with potassium salt of tannic acid in water; antihistamines in the form of tannate salt are generally quite stable and may be administered in such form without untoward side effects |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090831 Cytotoxic agents |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | CA2666136A1 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
| 04/17/2008 | CA2665605A1 New isocarbostyril alkaloid derivatives |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910377A2 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 04/16/2008 | EP1910376A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 04/16/2008 | EP1910375A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 04/16/2008 | EP1910338A2 Heterotetracyclic compounds as tpo mimetics |
| 04/16/2008 | EP1909788A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 04/16/2008 | CN101161654A Antineoplastic active canthardin derivative and method for preparing same |
| 04/16/2008 | CN101161653A Method for preparing novel Pranoprofen key intermediates |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358365 Process for the controlled increase in the molecular weight of polyethylenes |
| 04/15/2008 | US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/15/2008 | US7358259 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/15/2008 | US7358246 5-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; contraceptive, menopause; reduces risk of uterine cancers coused by treating with estrogen receptor (ER) agonists |
| 04/15/2008 | US7358244 Azabicycloalkane compounds |
| 04/15/2008 | CA2337452C Process for the preparation of 4,5-diamino shikimic acid derivatives |
| 04/10/2008 | WO2008042735A1 Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines |
| 04/10/2008 | WO2008028141A3 Raf inhibitor compounds and methods of use thereof |
| 04/10/2008 | WO2008012361A3 Dimethano-[1,3] dioxocino [6,5-d] pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007092535A3 4-acylaminopyridine derivative mediated neurogenesis |
| 04/10/2008 | WO2007019180A3 Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 04/10/2008 | US20080085925 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 04/10/2008 | US20080085469 Novel photoacid generators, resist compositions, and patterning process |
| 04/09/2008 | EP1908755A1 Therapeutic agent for restenosis |
| 04/09/2008 | EP1908752A1 Novel 2-quinolone derivative |
| 04/09/2008 | EP1907395A1 Abca1 elevating compounds |
| 04/09/2008 | EP1907394A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 04/09/2008 | EP1907371A1 Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | CN101160315A Cytoskeletal active compounds, composition and use |
| 04/09/2008 | CN101160049A Spiroketal-substituted cyclic ketoenols |
| 04/09/2008 | CN100379742C New tricyclic derivatives as LTD4 antagonists |
| 04/08/2008 | US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/08/2008 | US7354929 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |
| 04/08/2008 | US7354927 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
| 04/08/2008 | US7354925 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists |
| 04/08/2008 | US7354916 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | CA2203183C Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine |
| 04/08/2008 | CA2182504C Process for the preparation of a salt of clavulanic acid |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038030A2 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer |
| 04/03/2008 | US20080081910 5-HT1A receptor antagonists; modulating serotonin levels; central nervous system disorders; antidepressants; synthesis |
| 04/03/2008 | US20080081902 Capping, polymerizing and separating failure sequences; kits for purifying oligonucleotides and polynucleotides |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080081803 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/03/2008 | CA2665339A1 Dispiro tetraoxane compounds |
| 04/03/2008 | CA2664358A1 Diarylketimine derivative |
| 04/02/2008 | EP1905773A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/02/2008 | EP1904501A2 Chemical compounds |
| 04/02/2008 | EP1904477A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 04/02/2008 | EP1904454A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 04/02/2008 | EP1453506B1 Topoisomerase poison agents |
| 04/02/2008 | CN101155785A Novel adenosine a3 receptor modulators |